28 results
8-K
EX-99.1
AXLA
Axcella Health Inc.
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
Agency (MHRA) and Ethics Committee approval, a Phase 2a clinical trial led by researchers at the Radcliffe Department of Medicine at the University
DEF 14A
AXLA
Axcella Health Inc.
3 Apr 20
Definitive proxy
4:15pm
and recommending to the board of directors a code of business conduct and ethics and a set of corporate governance guidelines; and
overseeing the evaluation … and Ethics
We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
;
developing and recommending to the board of directors a code of business conduct and ethics and a set of corporate governance guidelines;
overseeing … an existing pledge).
Code of Business Conduct and Ethics
We have adopted a written code of business conduct and ethics that applies to our directors
424B4
h5yxef9x5gu3wqt
9 May 19
Prospectus supplement with pricing info
4:29pm
DRS/A
p9838w5n
15 Mar 19
Draft registration statement (amended)
12:00am
S-1/A
aa4nh3fb6zpi9h25
30 Apr 19
IPO registration (amended)
6:06am
DRS
8ahg974 es
28 Jan 19
Draft registration statement
12:00am
S-1
3ubk n1md
12 Apr 19
IPO registration
7:02am
10-K
29wjp8
23 Mar 20
Annual report
4:12pm